Out of Stock

This item is currently unavailable

The 2021-2026 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)

Out of Stock

Price data last checked 27 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Gone for 204 days. Could come back at any time — we're watching for you.

Out of stock 204 days · last price £795 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 704 days • 704 data points (No recent data available)

Historical
Generating forecast...
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 08 July 2024 30 December 2024 24 June 2025 17 December 2025 11 June 2026

Price Distribution

Price distribution over 704 days • 1 price levels

Days at Price
704 days 0 176 352 528 704 £795 Days at Price

Price Analysis

Most common price: £795 (704 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 704 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
13 February 2020
Listed Since
13 December 2019

Similar Products You Might Like

The 2021-2026 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)
95% match

The 2021-2026 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)

Out of Stock 11 Jun 2026
Esophageal Cancer: Epidemiology, Diagnosis and Treatment
95% match

Esophageal Cancer: Epidemiology, Diagnosis and Treatment

Brand: Nova Science Publishers

£80.65 01 May 2026
Esophageal Cancer: Prevention, Diagnosis and Therapy
95% match

Esophageal Cancer: Prevention, Diagnosis and Therapy

Out of Stock 06 Jul 2026
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
95% match

The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products

Out of Stock 17 Jun 2026
Esophageal Cancer - Cell and Molecular Biology, Biomarkers, Nutrition and Treatment
95% match

Esophageal Cancer - Cell and Molecular Biology, Biomarkers, Nutrition and Treatment

IntechOpen

£119.00 01 May 2026
Esophageal Cancer: Prevention, Diagnosis and Therapy
95% match

Esophageal Cancer: Prevention, Diagnosis and Therapy

Springer

£80.50 03 Jul 2026
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India
95% match

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India

£595.00 20 Jun 2026
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China
95% match

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China

£595.00 09 Mar 2026
Esophageal Cancer, An Issue of Thoracic Surgery Clinics (Volume 32-4) (The Clinics: Internal Medicine, Volume 32-4)
95% match

Esophageal Cancer, An Issue of Thoracic Surgery Clinics (Volume 32-4) (The Clinics: Internal Medicine, Volume 32-4)

Elsevier

£83.87 07 Jul 2026
The 2025-2030 World Outlook for Esophagus-Targeting Smart Pills
95% match

The 2025-2030 World Outlook for Esophagus-Targeting Smart Pills

Out of Stock 01 Jul 2026
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in North America & the Caribbean
95% match

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in North America & the Caribbean

£425.00 01 Jul 2026
Esophageal Cancer: Diagnosis and Treatment
95% match

Esophageal Cancer: Diagnosis and Treatment

Springer

£86.42 05 Jul 2026
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States
94% match

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States

£595.00 18 Jun 2026
Esophageal Cancer and Beyond
94% match

Esophageal Cancer and Beyond

IntechOpen

£95.74 07 Mar 2026
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Japan
94% match

The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Japan

£595.00 19 May 2026
The 2025-2030 World Outlook for Carcinoembryonic Antigen
94% match

The 2025-2030 World Outlook for Carcinoembryonic Antigen

Out of Stock 23 Jun 2026
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
94% match

The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£885.00 13 Jun 2026
The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies
94% match

The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies

Out of Stock 12 Jun 2026
Risk Factors and Therapy of Esophagus Cancer
94% match

Risk Factors and Therapy of Esophagus Cancer

Springer

£80.35 12 Apr 2026
Risk Factors and Therapy of Esophagus Cancer
94% match

Risk Factors and Therapy of Esophagus Cancer

Springer

£95.73 06 Jul 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States
94% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States

£520.00 13 Jun 2026
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
94% match

The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£795.00 03 Jul 2026
The 2023-2028 World Outlook for Carcinoembryonic Antigen
94% match

The 2023-2028 World Outlook for Carcinoembryonic Antigen

£795.00 16 Jun 2026
Esophageal Diseases: Diagnosis and Treatment
94% match

Esophageal Diseases: Diagnosis and Treatment

Out of Stock 01 Jul 2026